2030, Clinical Laboratory Services Market Size Industry Report 2023 - Benzinga
| SKHHY Stock | USD 18.51 0.38 2.10% |
Slightly above 55% of Sonic Healthcare's investors are presently thinking to get in. The analysis of overall sentiment of trading Sonic Healthcare Ltd pink sheet suggests that some investors are interested at this time. Sonic Healthcare's investing sentiment can be driven by a variety of factors including economic data, Sonic Healthcare's earnings reports, geopolitical events, and overall market trends.
Sonic |
2030, Clinical Laboratory Services Market Size Industry Report 2023 Benzinga
Read at news.google.com
 |
Sonic Healthcare Fundamental Analysis
We analyze Sonic Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sonic Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sonic Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Sonic Healthcare is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Sonic Healthcare Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sonic Healthcare pink sheet to make a market-neutral strategy. Peer analysis of Sonic Healthcare could also be used in its relative valuation, which is a method of valuing Sonic Healthcare by comparing valuation metrics with similar companies.
Peers
Sonic Healthcare Related Equities
| MYNZ | Mainz Biomed | 9.52 | ||||
| BDSX | Biodesix | 8.27 | ||||
| INBS | Intelligent Bio | 6.62 | ||||
| CDNA | Caredx | 4.19 | ||||
| CSTL | Castle Biosciences | 3.59 | ||||
| NTRA | Natera | 2.39 | ||||
| PRPH | ProPhase Labs | 1.35 | ||||
| CRL | Charles River | 0.92 | ||||
| PRPO | Precipio | 0.85 | ||||
| FONR | Fonar | 0.18 | ||||
| QGEN | Qiagen NV | 0.02 | ||||
| TWST | Twist Bioscience | 0.13 | ||||
| PRE | Prenetics Global | 0.22 | ||||
| STIM | Neuronetics | 2.06 | ||||
| LZAGF | Lonza Group | 3.88 | ||||
| APDN | Applied DNA | 5.88 |
Additional Tools for Sonic Pink Sheet Analysis
When running Sonic Healthcare's price analysis, check to measure Sonic Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonic Healthcare is operating at the current time. Most of Sonic Healthcare's value examination focuses on studying past and present price action to predict the probability of Sonic Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonic Healthcare's price. Additionally, you may evaluate how the addition of Sonic Healthcare to your portfolios can decrease your overall portfolio volatility.